mercaptoethanol has been researched along with Hematologic Malignancies in 1 studies
Mercaptoethanol: A water-soluble thiol derived from hydrogen sulfide and ethanol. It is used as a reducing agent for disulfide bonds and to protect sulfhydryl groups from oxidation.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In routine diagnostics of hematologic malignancies isolation of high-quality RNA is a prerequisite." | 5.39 | Addition of β-mercaptoethanol is a prerequisite for high-quality RNA isolation using QIAsymphony technology as demonstrated by detection of molecular aberrations in hematologic malignancies. ( Chu, IW; Geertsma-Kleinekoort, WM; Goudswaard, CS; Hogenbirk-Hupkes, PE; Valk, PJ; van de Werf, M; van der Poel-van de Luytgaarde, SC; van Hoven-Beijen, MA; van Kapel, J, 2013) |
| "In routine diagnostics of hematologic malignancies isolation of high-quality RNA is a prerequisite." | 1.39 | Addition of β-mercaptoethanol is a prerequisite for high-quality RNA isolation using QIAsymphony technology as demonstrated by detection of molecular aberrations in hematologic malignancies. ( Chu, IW; Geertsma-Kleinekoort, WM; Goudswaard, CS; Hogenbirk-Hupkes, PE; Valk, PJ; van de Werf, M; van der Poel-van de Luytgaarde, SC; van Hoven-Beijen, MA; van Kapel, J, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| van der Poel-van de Luytgaarde, SC | 1 |
| Geertsma-Kleinekoort, WM | 1 |
| Goudswaard, CS | 1 |
| Hogenbirk-Hupkes, PE | 1 |
| van Hoven-Beijen, MA | 1 |
| van de Werf, M | 1 |
| Chu, IW | 1 |
| van Kapel, J | 1 |
| Valk, PJ | 1 |
1 other study available for mercaptoethanol and Hematologic Malignancies
| Article | Year |
|---|---|
Addition of β-mercaptoethanol is a prerequisite for high-quality RNA isolation using QIAsymphony technology as demonstrated by detection of molecular aberrations in hematologic malignancies.
Topics: Chromosome Aberrations; Fusion Proteins, bcr-abl; Hematologic Neoplasms; Humans; Hydroxymethylbilane | 2013 |